NPI: 1104829159 · BURLINGTON, NC 27215 · Clinical Medical Laboratory · NPI assigned 05/23/2005
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VICE PRESIDENT) |
| NPI Enumeration Date | 05/23/2005 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,989,689 | $9.69M |
| 2019 | 2,350,649 | $8.29M |
| 2020 | 1,804,929 | $8.89M |
| 2021 | 2,416,016 | $11.45M |
| 2022 | 2,198,748 | $8.52M |
| 2023 | 2,605,824 | $8.51M |
| 2024 | 1,928,952 | $4.39M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 138,784 | 124,086 | $5.06M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 76,918 | 74,983 | $2.91M |
| 84443 | Thyroid stimulating hormone (TSH) | 829,966 | 813,015 | $2.69M |
| 80053 | Comprehensive metabolic panel | 1,207,124 | 1,157,205 | $2.66M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 361,193 | 348,670 | $2.63M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 478,297 | 470,549 | $2.63M |
| 80061 | Lipid panel | 984,102 | 966,487 | $2.60M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 363,058 | 350,466 | $2.60M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,133,124 | 1,078,892 | $1.85M |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 8,696 | 8,521 | $1.80M |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 5,920 | 5,889 | $1.77M |
| 83036 | Hemoglobin; glycosylated (A1C) | 836,344 | 821,118 | $1.58M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 79,743 | 65,286 | $1.45M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 121,618 | 120,612 | $1.00M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 208,440 | 204,924 | $971K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 110,791 | 106,709 | $966K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 158,792 | 157,373 | $922K |
| 86003 | 33,297 | 32,700 | $898K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 55,415 | 53,904 | $622K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 48,394 | 45,948 | $525K |
| 80074 | 54,672 | 53,014 | $520K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 259,415 | 244,602 | $486K |
| 84439 | 280,474 | 274,679 | $451K | |
| 84153 | 109,579 | 107,704 | $444K | |
| 86803 | 137,748 | 135,821 | $438K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 42,529 | 38,883 | $418K |
| 82607 | 159,526 | 156,797 | $418K | |
| 86235 | 16,736 | 16,331 | $416K | |
| 36415 | Collection of venous blood by venipuncture | 1,057,253 | 988,641 | $409K |
| 82274 | 97,820 | 95,403 | $403K | |
| 88312 | 14,296 | 14,256 | $395K | |
| 86480 | 44,162 | 43,408 | $388K | |
| 82746 | 130,926 | 128,935 | $384K | |
| 80050 | General health panel | 22,703 | 20,303 | $370K |
| 84403 | 59,655 | 58,548 | $359K | |
| 83013 | 25,089 | 24,845 | $323K | |
| 82043 | 204,546 | 200,593 | $298K | |
| 83970 | 24,377 | 23,781 | $293K | |
| 82728 | 104,748 | 102,058 | $289K | |
| 87536 | 10,089 | 9,819 | $286K | |
| 88313 | 8,641 | 8,622 | $284K | |
| 80081 | 6,445 | 6,245 | $271K | |
| 88341 | 3,457 | 3,403 | $271K | |
| 81257 | 571 | 570 | $265K | |
| 82570 | 173,779 | 169,310 | $256K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 95,464 | 92,157 | $250K |
| 87186 | 96,119 | 92,438 | $240K | |
| 86769 | 9,565 | 9,421 | $238K | |
| 87522 | Neg quan hep c or qual rna | 12,146 | 11,887 | $230K |
| 88342 | 5,978 | 5,878 | $213K | |
| 83550 | 111,016 | 108,424 | $201K | |
| 86592 | 213,020 | 208,848 | $198K | |
| 87902 | 1,576 | 1,523 | $198K | |
| 82670 | 33,542 | 32,882 | $194K | |
| 87088 | 100,918 | 97,179 | $190K | |
| 81329 | 3,478 | 3,441 | $188K | |
| 87340 | 100,325 | 99,061 | $179K | |
| 84481 | 51,699 | 50,678 | $173K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4,059 | 3,771 | $173K |
| 84402 | 26,791 | 26,338 | $168K | |
| 83540 | 123,000 | 120,023 | $167K | |
| 87517 | 8,137 | 8,064 | $161K | |
| 88142 | 21,898 | 21,473 | $160K | |
| 85027 | 121,356 | 118,610 | $158K | |
| 86038 | 59,571 | 58,405 | $158K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 1,446 | 1,434 | $146K |
| 83880 | 11,740 | 11,287 | $144K | |
| 81001 | 230,550 | 223,828 | $143K | |
| 84436 | 101,268 | 99,497 | $136K | |
| 87070 | 55,635 | 54,216 | $136K | |
| 83001 | 42,179 | 41,510 | $135K | |
| 81003 | 302,283 | 294,983 | $131K | |
| 86706 | 46,939 | 46,474 | $125K | |
| 84480 | 44,073 | 43,440 | $125K | |
| 82652 | 19,759 | 19,284 | $123K | |
| 81374 | 3,411 | 3,371 | $116K | |
| 88141 | 23,923 | 23,763 | $114K | |
| 83002 | 35,798 | 35,234 | $109K | |
| 86704 | 32,666 | 32,427 | $105K | |
| 86696 | 23,105 | 22,493 | $104K | |
| 87077 | 53,578 | 52,020 | $100K | |
| 87507 | 405 | 398 | $100K | |
| 86376 | 30,697 | 30,158 | $97K | |
| 86140 | 83,374 | 79,890 | $95K | |
| 84702 | 45,013 | 36,324 | $94K | |
| 84550 | 111,176 | 108,825 | $93K | |
| 84146 | 29,000 | 28,263 | $92K | |
| 82105 | 21,924 | 21,439 | $92K | |
| 83735 | 56,265 | 52,422 | $91K | |
| 86708 | 21,673 | 21,394 | $86K | |
| 80076 | 53,797 | 52,690 | $83K | |
| 83516 | 14,785 | 14,423 | $82K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,894 | 1,875 | $79K |
| 82785 | 24,255 | 23,946 | $77K | |
| 86360 | 5,141 | 4,982 | $77K | |
| 87481 | 2,859 | 2,710 | $77K | |
| 87529 | 6,426 | 6,278 | $76K | |
| 82378 | 19,963 | 17,817 | $75K | |
| 86762 | 41,435 | 40,936 | $73K | |
| 99199 | Unlisted special service, procedure or report | 13,345 | 11,864 | $73K |
| 84479 | 61,315 | 60,468 | $73K | |
| 84144 | 19,114 | 18,026 | $72K | |
| 88304 | 5,209 | 5,156 | $70K | |
| 83655 | 34,846 | 34,247 | $70K | |
| 85610 | 75,193 | 68,434 | $69K | |
| 86160 | 13,129 | 12,796 | $69K | |
| 82784 | 18,435 | 17,865 | $68K | |
| 86225 | 18,755 | 18,399 | $65K | |
| 87209 | 12,081 | 10,845 | $65K | |
| 86695 | 20,270 | 19,680 | $63K | |
| 87081 | 48,121 | 47,069 | $63K | |
| 81401 | 411 | 410 | $63K | |
| 86300 | 10,241 | 9,275 | $63K | |
| 87150 | 13,731 | 13,505 | $63K | |
| 85730 | 47,966 | 46,297 | $61K | |
| 86431 | 50,818 | 49,955 | $60K | |
| 86800 | 16,521 | 16,128 | $60K | |
| 81251 | 187 | 186 | $59K | |
| 85652 | 114,651 | 110,656 | $58K | |
| 84154 | 16,272 | 16,127 | $57K | |
| 86787 | 18,387 | 18,196 | $57K | |
| 82627 | 12,757 | 12,570 | $55K | |
| 86147 | 4,201 | 4,129 | $54K | |
| 84681 | 7,759 | 7,604 | $52K | |
| 86200 | 21,909 | 21,523 | $51K | |
| 82533 | 10,681 | 10,236 | $50K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 983 | 968 | $46K |
| 86141 | 13,766 | 13,619 | $42K | |
| 86304 | 8,882 | 8,357 | $41K | |
| 86665 | 3,705 | 3,621 | $41K | |
| 83520 | 8,543 | 8,388 | $41K | |
| 86361 | 4,608 | 4,485 | $40K | |
| 87901 | 249 | 248 | $40K | |
| 83690 | 22,812 | 22,297 | $40K | |
| 88307 | 586 | 585 | $38K | |
| 86635 | 3,782 | 3,518 | $38K | |
| 87900 | 510 | 498 | $38K | |
| 88112 | 2,012 | 1,953 | $38K | |
| 88185 | 242 | 238 | $38K | |
| 84100 | 35,124 | 32,262 | $37K | |
| 86317 | 17,562 | 17,407 | $37K | |
| 84445 | 3,937 | 3,872 | $36K | |
| 81243 | 1,490 | 1,476 | $36K | |
| 82550 | 20,993 | 20,142 | $34K | |
| 80347 | 8,483 | 8,360 | $33K | |
| 86765 | 14,784 | 14,635 | $33K | |
| 87177 | 12,161 | 10,907 | $32K | |
| 87338 | 15,625 | 15,467 | $32K | |
| 87075 | 8,546 | 8,214 | $31K | |
| 82672 | 5,038 | 4,988 | $31K | |
| 86735 | 13,307 | 13,191 | $31K | |
| 87625 | 1,144 | 1,134 | $31K | |
| 86146 | 2,205 | 2,167 | $31K | |
| 86780 | 8,951 | 8,770 | $30K | |
| 87427 | 9,482 | 9,291 | $30K | |
| 81200 | 175 | 174 | $30K | |
| 83615 | 25,456 | 23,862 | $30K | |
| 80361 | 11,160 | 10,902 | $30K | |
| 83525 | 13,047 | 12,855 | $29K | |
| 81330 | 175 | 174 | $29K | |
| 88173 | 637 | 627 | $29K | |
| 87045 | 9,538 | 9,350 | $28K | |
| 82977 | 24,181 | 23,520 | $28K | |
| 83721 | 12,973 | 12,803 | $28K | |
| 86301 | 5,239 | 4,789 | $27K | |
| 86677 | 4,052 | 3,920 | $27K | |
| 84165 | 7,851 | 7,498 | $27K | |
| 84450 | 35,618 | 34,440 | $27K | |
| 82024 | 3,415 | 3,332 | $26K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 988 | 959 | $26K |
| 84156 | 28,712 | 27,151 | $26K | |
| 82565 | 32,744 | 31,332 | $25K | |
| 80365 | 10,466 | 10,246 | $25K | |
| 83090 | 5,472 | 5,388 | $25K | |
| 86850 | 31,172 | 30,687 | $23K | |
| 84460 | 26,234 | 25,481 | $23K | |
| 80164 | 6,567 | 6,183 | $23K | |
| 82140 | 4,315 | 4,132 | $23K | |
| 82951 | 13,030 | 12,859 | $23K | |
| 82150 | 17,604 | 17,218 | $23K | |
| 86334 | 3,494 | 3,382 | $22K | |
| 81162 | 12 | 12 | $22K | |
| 84425 | 3,724 | 3,670 | $21K | |
| 83883 | 3,612 | 3,380 | $21K | |
| 80069 | 12,563 | 11,957 | $21K | |
| 82950 | 27,174 | 26,448 | $21K | |
| 80348 | 10,771 | 10,504 | $20K | |
| 82947 | 41,090 | 40,078 | $20K | |
| 80373 | 9,985 | 9,817 | $20K | |
| 87906 | 234 | 233 | $19K | |
| 80354 | 10,563 | 10,349 | $19K | |
| 80358 | 10,218 | 10,047 | $19K | |
| 83498 | 3,188 | 3,126 | $19K | |
| 84075 | 21,380 | 20,652 | $18K | |
| 83992 | 6,307 | 6,238 | $18K | |
| 82310 | 19,376 | 18,654 | $18K | |
| 86709 | 7,282 | 7,234 | $18K | |
| 85060 | 4,234 | 4,145 | $18K | |
| 80353 | 9,887 | 9,733 | $18K | |
| 83521 | 1,378 | 1,274 | $17K | |
| 82330 | 4,233 | 4,117 | $17K | |
| 80359 | 10,154 | 9,954 | $17K | |
| 82248 | 17,471 | 16,673 | $17K | |
| 87535 | 2,563 | 2,549 | $17K | |
| 87046 | 9,518 | 9,321 | $17K | |
| 84520 | 27,037 | 25,943 | $17K | |
| 80372 | 9,812 | 9,661 | $17K | |
| 84270 | 3,712 | 3,670 | $17K | |
| 82247 | 24,178 | 23,244 | $17K | |
| 84207 | 2,175 | 2,159 | $16K | |
| 87480 | 6,216 | 6,104 | $16K | |
| 83921 | 2,658 | 2,573 | $16K | |
| 82397 | 3,750 | 3,683 | $16K | |
| 83014 | 12,306 | 12,216 | $16K | |
| 86256 | 2,395 | 2,353 | $16K | |
| 86364 | 5,398 | 5,382 | $16K | |
| 82507 | 1,084 | 1,043 | $16K | |
| 87510 | 6,213 | 6,101 | $16K | |
| 80197 | 4,328 | 3,601 | $15K | |
| 87660 | 6,191 | 6,079 | $15K | |
| 83695 | 2,286 | 2,282 | $15K | |
| 82040 | 20,989 | 20,294 | $15K | |
| 86664 | 2,519 | 2,459 | $15K | |
| 84155 | 23,628 | 22,691 | $15K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 45 | 45 | $15K |
| 84703 | 13,184 | 12,865 | $15K | |
| 83993 | 3,294 | 3,248 | $14K | |
| 85045 | 19,983 | 19,235 | $13K | |
| 81596 | 1,196 | 1,170 | $13K | |
| 80178 | 4,707 | 4,346 | $13K | |
| 86901 | 36,479 | 35,953 | $13K | |
| 86900 | 36,520 | 35,993 | $13K | |
| 86341 | 1,285 | 1,272 | $13K | |
| 87563 | 4,275 | 4,221 | $13K | |
| 87350 | 4,318 | 4,285 | $12K | |
| 82172 | 4,134 | 4,098 | $12K | |
| 83021 | 2,180 | 2,105 | $12K | |
| 87324 | 3,167 | 3,107 | $12K | |
| 86705 | 4,641 | 4,602 | $11K | |
| 84305 | 3,262 | 3,163 | $11K | |
| 80051 | 7,068 | 6,833 | $11K | |
| 86381 | 2,449 | 2,422 | $11K | |
| 86707 | 3,874 | 3,841 | $11K | |
| 84466 | 2,535 | 2,478 | $11K | |
| 87538 | 2,196 | 2,158 | $10K | |
| 86255 | 3,713 | 3,652 | $10K | |
| 84132 | 15,632 | 14,918 | $10K | |
| 84410 | 713 | 695 | $10K | |
| 99001 | 3,180 | 2,611 | $10K | |
| 85379 | 3,521 | 3,457 | $10K | |
| 82626 | 2,271 | 2,253 | $9K | |
| 87329 | 2,766 | 2,642 | $9K | |
| 83010 | 3,214 | 3,140 | $9K | |
| 87650 | 514 | 514 | $9K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 176 | 175 | $9K |
| 86593 | 3,472 | 3,319 | $9K | |
| 84482 | 1,668 | 1,654 | $9K | |
| 86008 | 472 | 466 | $8K | |
| 80326 | 6,140 | 6,074 | $8K | |
| 85613 | 2,724 | 2,676 | $8K | |
| 80377 | 6,161 | 6,094 | $8K | |
| 84478 | 7,178 | 6,327 | $8K | |
| 0097U | 38 | 38 | $8K | |
| 82390 | 3,329 | 3,262 | $8K | |
| 84295 | 14,085 | 13,479 | $8K | |
| 86359 | 1,419 | 1,382 | $8K | |
| 83945 | 1,087 | 1,044 | $8K | |
| 84166 | 1,344 | 1,315 | $8K | |
| 80364 | 6,131 | 6,067 | $7K | |
| 86037 | 1,108 | 1,093 | $7K | |
| 82668 | 1,645 | 1,618 | $7K | |
| 80341 | 6,160 | 6,096 | $7K | |
| 80337 | 6,198 | 6,133 | $7K | |
| 82088 | 757 | 739 | $7K | |
| 82435 | 13,580 | 13,015 | $7K | |
| 80370 | 6,216 | 6,152 | $7K | |
| 87255 | 816 | 806 | $7K | |
| 86618 | 720 | 703 | $7K | |
| 82103 | 2,125 | 2,084 | $7K | |
| 86258 | 2,150 | 2,146 | $7K | |
| 80366 | 6,234 | 6,162 | $7K | |
| 80367 | 6,134 | 6,070 | $7K | |
| 80331 | 6,130 | 6,065 | $6K | |
| 80355 | 6,249 | 6,171 | $6K | |
| 80368 | 6,268 | 6,197 | $6K | |
| 80360 | 6,214 | 6,150 | $6K | |
| 80338 | 6,204 | 6,138 | $6K | |
| 80371 | 6,129 | 6,065 | $6K | |
| 80334 | 6,197 | 6,132 | $6K | |
| 80357 | 6,165 | 6,095 | $6K | |
| 80344 | 6,130 | 6,065 | $6K | |
| 86015 | 2,283 | 2,257 | $6K | |
| 80324 | 3,647 | 3,526 | $6K | |
| 86694 | 2,108 | 2,071 | $6K | |
| 82465 | 9,555 | 9,322 | $6K | |
| 88344 | 16 | 16 | $6K | |
| 80177 | 1,541 | 1,493 | $6K | |
| 83020 | 3,628 | 3,608 | $6K | |
| 84432 | 1,282 | 1,256 | $6K | |
| 86162 | 1,503 | 1,480 | $6K | |
| 82340 | 2,018 | 1,946 | $5K | |
| 80346 | 2,192 | 2,089 | $5K | |
| 85598 | 1,144 | 1,121 | $5K | |
| 80159 | 848 | 646 | $5K | |
| 88184 | 230 | 228 | $5K | |
| 87101 | 2,577 | 2,491 | $5K | |
| 81025 | 4,619 | 4,521 | $5K | |
| 84630 | 2,913 | 2,880 | $5K | |
| 85732 | 2,320 | 2,292 | $5K | |
| 85018 | 15,600 | 15,254 | $4K | |
| 85014 | 11,931 | 11,678 | $4K | |
| 84300 | 1,999 | 1,931 | $4K | |
| 82525 | 1,523 | 1,493 | $4K | |
| 84484 | 682 | 649 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 179 | 175 | $4K |
| 83704 | 438 | 438 | $4K | |
| 86663 | 643 | 607 | $4K | |
| 87205 | 2,619 | 2,420 | $4K | |
| 86702 | 875 | 855 | $4K | |
| 86060 | 2,832 | 2,765 | $4K | |
| 80185 | 626 | 574 | $4K | |
| 88189 | 111 | 110 | $4K | |
| 82085 | 1,836 | 1,809 | $4K | |
| 85660 | 2,027 | 1,949 | $4K | |
| 86790 | 234 | 233 | $3K | |
| 84560 | 1,223 | 1,179 | $3K | |
| 83003 | 137 | 134 | $3K | |
| 82232 | 423 | 384 | $3K | |
| 84080 | 620 | 609 | $3K | |
| 84105 | 1,054 | 1,013 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 181 | 180 | $3K |
| 86644 | 722 | 696 | $3K | |
| 84134 | 601 | 506 | $3K | |
| 85240 | 788 | 760 | $3K | |
| 82436 | 981 | 943 | $3K | |
| 81256 | 110 | 108 | $3K | |
| 82747 | 780 | 771 | $3K | |
| 88360 | 24 | 24 | $3K | |
| 86231 | 3,217 | 3,210 | $3K | |
| 84540 | 945 | 902 | $3K | |
| 84133 | 1,080 | 1,035 | $3K | |
| 80299 | 440 | 430 | $3K | |
| 82952 | 5,672 | 5,540 | $3K | |
| 89055 | 1,775 | 1,717 | $3K | |
| 84244 | 610 | 600 | $3K | |
| 81241 | 218 | 216 | $3K | |
| 85246 | 619 | 597 | $3K | |
| 84392 | 987 | 949 | $3K | |
| 85041 | 6,546 | 6,417 | $2K | |
| 85670 | 1,738 | 1,703 | $2K | |
| 84378 | 2,607 | 2,589 | $2K | |
| 86331 | 789 | 773 | $2K | |
| 87206 | 1,377 | 1,175 | $2K | |
| 80156 | 430 | 416 | $2K | |
| 87521 | Neg quan hep c or qual rna | 499 | 491 | $2K |
| 82615 | 474 | 472 | $2K | |
| 86308 | 1,379 | 1,355 | $2K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 38 | 37 | $2K |
| 86005 | 1,360 | 1,344 | $2K | |
| 80055 | 185 | 180 | $2K | |
| 85048 | 6,594 | 6,464 | $2K | |
| 86701 | 595 | 580 | $2K | |
| 85007 | 2,670 | 2,648 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 196 | 195 | $2K |
| 82653 | 502 | 496 | $2K | |
| 81206 | 47 | 45 | $2K | |
| 81490 | 58 | 57 | $2K | |
| 83935 | 830 | 810 | $2K | |
| 87799 | 125 | 118 | $2K | |
| 81270 | 65 | 64 | $2K | |
| 87076 | 594 | 582 | $2K | |
| 81207 | 46 | 44 | $1K | |
| 85245 | 426 | 409 | $1K | |
| 81050 | 914 | 877 | $1K | |
| 86171 | 1,208 | 1,185 | $1K | |
| 82239 | 527 | 477 | $1K | |
| 80175 | 485 | 472 | $1K | |
| 83986 | 956 | 917 | $1K | |
| 83835 | 304 | 288 | $1K | |
| 82166 | 584 | 582 | $1K | |
| 87210 | 685 | 647 | $1K | |
| 82575 | 722 | 693 | $1K | |
| 83519 | 129 | 125 | $1K | |
| 86645 | 263 | 256 | $1K | |
| 86335 | 99 | 98 | $1K | |
| 82107 | 206 | 205 | $1K | |
| 86692 | 83 | 83 | $960.00 | |
| 82553 | 235 | 227 | $959.32 | |
| 87493 | 144 | 144 | $923.97 | |
| 82679 | 129 | 124 | $899.98 | |
| 82365 | 170 | 167 | $885.81 | |
| 82787 | 82 | 81 | $878.21 | |
| 87040 | 189 | 175 | $854.05 | |
| 85705 | 145 | 144 | $839.39 | |
| 82610 | 527 | 467 | $826.85 | |
| 85306 | 200 | 198 | $792.85 | |
| 82374 | 1,041 | 987 | $774.32 | |
| 82157 | 225 | 220 | $722.65 | |
| 84590 | 362 | 355 | $678.51 | |
| 86671 | 355 | 349 | $636.14 | |
| 86357 | 337 | 334 | $628.27 | |
| 81422 | 774 | 774 | $600.00 | |
| 80356 | 238 | 234 | $591.05 | |
| 86777 | 135 | 125 | $587.40 | |
| 87106 | 122 | 118 | $560.84 | |
| 88302 | 37 | 37 | $520.49 | |
| 80202 | 72 | 37 | $520.02 | |
| 82542 | 130 | 127 | $500.37 | |
| 86337 | 79 | 76 | $489.54 | |
| 80162 | 68 | 61 | $472.24 | |
| 82523 | 102 | 102 | $462.00 | |
| 82985 | 160 | 157 | $458.11 | |
| 81240 | 66 | 66 | $456.82 | |
| 83718 | 449 | 441 | $447.08 | |
| 85004 | 154 | 149 | $443.89 | |
| 85384 | 297 | 287 | $431.04 | |
| 81015 | 323 | 323 | $424.16 | |
| 82164 | 215 | 213 | $406.00 | |
| 86356 | 295 | 291 | $389.66 | |
| 80165 | 94 | 94 | $376.23 | |
| 86036 | 386 | 378 | $343.27 | |
| 86606 | 67 | 66 | $339.25 | |
| 82705 | 260 | 259 | $339.16 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 26 | 26 | $337.49 |
| 80184 | 44 | 44 | $332.86 | |
| 85049 | 150 | 146 | $316.05 | |
| 88311 | 27 | 26 | $313.10 | |
| 84446 | 115 | 114 | $285.82 | |
| 82131 | 42 | 41 | $271.22 | |
| 85597 | 69 | 66 | $258.30 | |
| 84152 | 106 | 105 | $230.94 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 164 | 162 | $230.00 |
| 85300 | 67 | 67 | $227.36 | |
| 82681 | 14 | 14 | $223.52 | |
| 87109 | 25 | 25 | $190.08 | |
| 86355 | 12 | 12 | $173.58 | |
| 82656 | 79 | 76 | $169.13 | |
| 87116 | 74 | 50 | $160.90 | |
| 80321 | 78 | 71 | $156.52 | |
| 80349 | 480 | 440 | $149.26 | |
| 83825 | 52 | 51 | $139.96 | |
| 82175 | 27 | 26 | $120.34 | |
| 88164 | 339 | 325 | $117.35 | |
| 80369 | 31 | 30 | $104.40 | |
| 82552 | 70 | 70 | $103.28 | |
| 83930 | 39 | 38 | $99.15 | |
| 85303 | 27 | 27 | $74.65 | |
| 87807 | 12 | 12 | $73.72 | |
| 87631 | 118 | 115 | $61.07 | |
| 82360 | 12 | 12 | $59.42 | |
| 86747 | 13 | 13 | $53.44 | |
| 82530 | 28 | 26 | $50.13 | |
| 86682 | 15 | 15 | $20.80 | |
| 86880 | 27 | 26 | $16.53 | |
| 83631 | 27 | 25 | $15.70 | |
| 86804 | 152 | 151 | $15.18 | |
| 82955 | 12 | 12 | $8.62 | |
| 80362 | 181 | 139 | $1.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 220 | 220 | $0.00 |
| 80339 | 15 | 13 | $0.00 | |
| 86336 | 224 | 222 | $0.00 | |
| 87102 | 52 | 51 | $0.00 | |
| 87905 | 52 | 51 | $0.00 | |
| 84140 | 12 | 12 | $0.00 | |
| 84163 | 42 | 42 | $0.00 | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 26 | 25 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 22 | 21 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 12 | 12 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 13 | 13 | $0.00 |
| 36416 | 270 | 185 | $0.00 | |
| 82677 | 163 | 161 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 74 | 73 | $0.00 |
| 80345 | 164 | 163 | $0.00 | |
| 80374 | 98 | 88 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 12 | 12 | $0.00 |
| 81229 | 14 | 12 | $0.00 | |
| 83789 | 12 | 12 | $0.00 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12 | 12 | $0.00 |
| 86226 | 12 | 12 | $0.00 | |
| 87593 | 18 | 18 | $0.00 | |
| 87581 | 26 | 26 | $0.00 | |
| 82642 | 13 | 13 | $0.00 | |
| 87486 | 25 | 25 | $0.00 | |
| 84591 | 26 | 26 | $0.00 | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17 | 17 | $0.00 |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 30 | 29 | $0.00 |
| 83874 | 12 | 12 | $0.00 | |
| 83605 | 12 | 12 | $0.00 | |
| 80320 | 16 | 16 | $0.00 | |
| 86738 | 14 | 14 | $0.00 |